Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-25-084044
Filing Date
2025-08-27
Accepted
2025-08-27 16:34:13
Documents
16
Effectiveness Date
2025-08-27

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2524290d1_s8.htm S-8 78335
2 EXHIBIT 4.4 tm2524290d1_ex4-4.htm EX-4.4 208870
3 EXHIBIT 5.1 tm2524290d1_ex5-1.htm EX-5.1 8517
4 EXHIBIT 23.1 tm2524290d1_ex23-1.htm EX-23.1 1879
5 EX-FILING FEES tm2524290d1_ex-filingfees.htm   iXBRL EX-FILING FEES 16717
6 GRAPHIC tm2524290d1_ex5-1img001.jpg GRAPHIC 6856
  Complete submission text file 0001104659-25-084044.txt   445398

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2524290d1_ex-filingfees_htm.xml XML 5317
Mailing Address 23 HATA'AS STREET KFAR SABA Israel 44425
Business Address 23 HATA'AS STREET KFAR SABA Israel 44425 97299741444
Quoin Pharmaceuticals, Ltd. (Filer) CIK: 0001671502 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: S-8 | Act: 33 | File No.: 333-289891 | Film No.: 251265777
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)